American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
Harold J. Burstein(Dana-Farber Cancer Institute), Jennifer J. Griggs(Michigan Medicine), Nancy E. Davidson(WinnMed), Thomas A. Buchholz(Scripps MD Anderson Cancer Center), Clifford A. Hudis(American Society of Clinical Oncology), Diana Rowden(BC Cancer Agency), Mark R. Somerfield(American Society of Clinical Oncology), Vered Stearns(Johns Hopkins University), Jerome Seidenfeld(BC Cancer Agency), Karen Gelmon(BC Cancer Agency), Eric P. Winer(University of Vermont), Alexander J. Solky(BC Cancer Agency), Eleftherios P. Mamounas(Orlando Health), Jennifer L. Malin(Woman's Hospital), MaryFran R. Sowers(BC Cancer Agency), Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), Ann Alexis Prestrud(Kentucky Educational Television), Holly Anderson(BC Cancer Agency)
Cited by 800
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k